American Center for Organ Restoration

Treatment Programs

ACOR delivers personalized treatment programs that manage the root causes of chronic inflammation, organ injury, metabolic imbalance, and selected organ-related cancers. Each program integrates advanced cellular therapies, immune modulation, metabolic recalibration, and targeted Regenerative interventions.

Our treatment programs are not based on "one size fits all." Rather they are precisely engineered therapeutic plans customized to the biology of each patient.

The ACOR Restoration Program

A Program Focused on Function, Structure, and Cellular Health

Organ dysfunction develops through a combination of inflammation, immune dysregulation, metabolic disturbance, and progressive tissue injury. ACOR program targets these mechanisms with the use of:

Fresh cord blood mesenchymal stem cells.
Allogeneic natural killer (NK) cells.
Autologous peripheral blood lymphocytes.
Growth factor–based signaling support.
Targeted peptides and polypeptides.
Metabolic and immune regulation strategies.

Organs Treated

Patients with chronic or progressive impairment of:

Liver.
Kidney.
Heart.
Lung.
Pancreas.
Organ systems affected by fibrotic or inflammatory processes.

Treatment Goals

Reduce inflammation at its biological source.
Improve tissue environment and cellular signaling.
Support healthier immune responses.
Promote structural repair and functional improvement.
Slow or reverse progression where biologically feasible.

This program represents the center's core philosophy: the treatment of disease at the level where disease actually begins – the cell.

The Liver Regeneration Program

A Special Program for One of the Most Complex Organs in Medicine

Liver disease can progress quietly over years before symptoms appear. Our Liver Regeneration Program integrates advanced cellular and immune technologies to address inflammation and fibrosis.

What Biologics ACOR Uses

Fresh cord blood MSCs.
NK cells with antifibrotic and immune-regulating properties.
Autologous lymphocyte-based immune reinforcement.
Growth factor-supported hepatocyte environment.
Emerging hepatocyte-like cell technologies.

Conditions Evaluated

Fatty liver disease (NAFLD / NASH).
Viral and non-viral hepatitis.
Fibrosis.
Cirrhosis (select stages).
Cholestatic and biliary disorders.
Acute liver injury.
Metabolic or inherited liver conditions.

Treatment Focus

Modulate inflammatory and fibrotic pathways.
Support hepatocyte activity.
Enhance metabolic function.
Improve liver resilience.

This program reflects decades of global expertise in liver transplantation, hepatobiliary medicine, regenerative biology, and immune therapeutics.

The Chronic Inflammation and Immune Dysregulation Program

The Biological Source of Organ Decline

Chronic inflammation is an indispensable component of nearly every major organ disease. It disrupts signaling, accelerates fibrosis, alters immune function, and undermines cellular repair mechanisms.

Conditions Treated

Systemic inflammation.
Autoimmune-associated organ damage.
Metabolic inflammation.
Inflammatory post-toxin or post-viral conditions.
Fibrosis-associated organ impairment.
Dysregulated immune responses.

Therapeutic Objectives

Reduce inflammatory cytokine signaling.
Support balanced immune modulation.
Promote tissue repair processes.
Improve metabolic and cellular communication.
Establish healthier long-term immune patterns.

This program forms the foundation for patients with multi-system involvement.

The Cellular Immunotherapy and Oncology Support Program

An Approach Inspired by Decades of Clinical Experience

For patients with cancers and immunocompromised tumor environments, the Center provides carefully selected cellular immunotherapies that complement existing oncology care.

Possible Components

Autologous lymphocyte infusion.
Allogeneic NK cell therapy.
Dendritic cell-based immune activation (when appropriate).
Growth factor and peptide support for immune stability.
Select targeted combinations evaluated case-by-case.

Conditions Evaluated

Solid tumors affecting the liver.
Select metastatic conditions involving the liver.
Immune-suppressed tumor microenvironments.
Patients who want additional immune support alongside conventional oncology care.

Important Note

All oncology-related cases undergo a rigorous review by our physicians to determine clinical suitability and biological alignment with Regenerative goals.

This is not a replacement for oncology care. It is a specialized adjunct in appropriate circumstances.

The Metabolic and Orphan Disease Regenerative Program

Conditions Where Standard Options Are Limited

Some metabolic and hereditary conditions create organ dysfunction long before symptoms arise. Our Center evaluates selected cases to determine whether targeted cellular or metabolic interventions may be biologically appropriate.

Possible Candidates Include

Inherited metabolic liver disorders.
Selected congenital enzyme deficiencies.
Metabolic-inflammatory disorders.
Rare conditions affecting organ integrity or regeneration.

A Personalized Treatment Design for Every Patient

While each program has defined principles, no patient receives a generic protocol.

Every treatment plan is the result of:

Disease history.
Laboratory findings.
Diagnostic imaging.
Immune and inflammatory markers.
Organ function assessments.
Metabolic signatures.
Patient-specific biological responses.

Explore Your Options

If you are having trouble with chronic inflammation, organ dysfunction, or a complex metabolic or immune-related condition, our physicians can conduct a detailed review of your case and determine which program may be suitable for you.

Restoring Hope. Restoring Life!

Give us a call today to see what our team can do for you and your loved ones.

Request a Consultation